Linustatin is a cyanogenic glycoside that can be isolated from linseed meal[1].

Linvoseltamab is a bispecific antibody targeting to both BCMA (TNFRSF17) and CD3 epsilon. Linvoseltamab shows safety profile and encouraging efficacy in relapsed/refractory multiple myeloma (RRMM) models[1][2].

Liothyronine (Standard) is the analytical standard of Liothyronine. This product is intended for research and analytical applications. Liothyronine is an active form of thyroid hormone. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2][3].

Liothyronine-13C6-1 is a 13C-labeled Liothyronine. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2].

Liothyronine-13C9,15N is the 13C and 15N labeled Liothyronine[1]. Liothyronine is an active form of thyroid hormone. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[2][3][4].

Lipid 1 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 10 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 10 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 10 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 10 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 14 is a potent ionizable lipid and can be used to synthesize lipid nanoparticles (LNPs)[1].

Lipid 14 is a potent ionizable lipid and can be used to synthesize lipid nanoparticles (LNPs)[1].

Lipid 14 is a potent ionizable lipid and can be used to synthesize lipid nanoparticles (LNPs)[1].

Lipid 15 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 15 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 15 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles[1].

Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles[1].

Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles[1].

Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles[1].

Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles[1].

Lipid 6 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 8 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 8 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 8 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 8 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid 8 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).

Lipid AX4 is an ionizable cationic lipid with the pKa of 6.89， and can be used the study for the formation of lipid nanoparticles (LNPs) for the delivery of mRNA in vivo[1].

Lipid C24 is a cationic ionizable lipid, and can be used in the formation of lipid nanoparticles (LNPs). Lipid C24 can be used for research of delivery of nucleic acids[1].

Lipid Membrane Translocating Peptide is a cell-penetrating peptide consisting of 13 amino acids[1].

Lipid X is a novel monosaccharide precursor of Lipid A (the active moiety of gram-negative endotoxin). Lipid X is protective against endotoxin administered to mice and sheep and against life-threatening gram-negative infections in mice[1].

Lipiferolide is an antiplasmodial agent (IC50: 1.8 μg/mL) that can be isolated from Liriodendron tulipifera. Lipiferolide also inhibits FPTase, and has antitumor activity[1][2].

Lipoic acid (Standard) is the analytical standard of Lipoic acid. This product is intended for research and analytical applications. Lipoic acid ((R)-(+)-α-Lipoic acid) is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. (R)-(+)-α-Lipoic acid is more effective than racemic Lipoic acid.

Lipoic acid (Standard) is the analytical standard of Lipoic acid. This product is intended for research and analytical applications. Lipoic acid ((R)-(+)-α-Lipoic acid) is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. (R)-(+)-α-Lipoic acid is more effective than racemic Lipoic acid.

Lipoic acid (Standard) is the analytical standard of Lipoic acid. This product is intended for research and analytical applications. Lipoic acid ((R)-(+)-α-Lipoic acid) is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. (R)-(+)-α-Lipoic acid is more effective than racemic Lipoic acid.

Lipoic acid (Standard) is the analytical standard of Lipoic acid. This product is intended for research and analytical applications. Lipoic acid ((R)-(+)-α-Lipoic acid) is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. (R)-(+)-α-Lipoic acid is more effective than racemic Lipoic acid.

Lipoprotein lipase, Pseudomonas sp (LPL) is a multifunctional enzyme from adipose tissue, heart and skeletal muscle, islets and macrophages. Lipoprotein lipase promotes normal lipoprotein metabolism, delivery and utilization of tissue-specific substrates. Lipoprotein lipase catalyzes the rate-limiting step of lipids in blood circulation[1][2].

Lipoprotein lipase, Pseudomonas sp (LPL) is a multifunctional enzyme from adipose tissue, heart and skeletal muscle, islets and macrophages. Lipoprotein lipase promotes normal lipoprotein metabolism, delivery and utilization of tissue-specific substrates. Lipoprotein lipase catalyzes the rate-limiting step of lipids in blood circulation[1][2].

Lipoprotein lipase, Pseudomonas sp (LPL) is a multifunctional enzyme from adipose tissue, heart and skeletal muscle, islets and macrophages. Lipoprotein lipase promotes normal lipoprotein metabolism, delivery and utilization of tissue-specific substrates. Lipoprotein lipase catalyzes the rate-limiting step of lipids in blood circulation[1][2].

Lipospondin is a bioactive peptide with anti-wrinkl effect and has been reported used as a cosmetic ingredient[1].

Lipoxygenase, general (LOX) is a dioxygenase, is often used in biochemical studies. Lipoxygenase, general catalyzes the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid[1].

Liproxstatin-1-13C6 is the 13C labled Liproxstatin-1 (HY-12726). Liproxstatin-1 is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM)[1].

Liproxstatin-1-15N is the 15N labled Liproxstatin-1 (HY-12726). Liproxstatin-1 is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM)[1].

Lipstatin is a very potent pancreatic lipase inhibitor can be isolated from Streptomyces toxytricini. Lipstatin inhibits the hydrolysis of trioleate by porcine pancreatic lipase with an IC50 of 0.14 μM[1].

Liptracker-green (fac-[Re(CO)3(phen)L]) is a cell-permeable fluorogenic probe that localizes to polar lipids, and can be used to label lipid droplets and other high lipid-content compartments in live and fixed cells using fluorescent microscopy.

Lipustobart is an IgG4-kappa, anti-PDCD1 (programmed cell death 1, PD1, PD-1, CD279) humanized monoclonal antibody. Lipustobart shows immunostimulant and antineoplastic activity[1].

Liquid Paraffin can be used as an excipient, such as excipient, lubricant. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also […]

Liraglutide-13C5,15N (tetraTFA)is the 13C and 15N labeledLiraglutide(HY-P0014)[1]. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus[2].

Liraglutide-d8 (triTFA) is the deuterium labeled Liraglutide (HY-P0014)[1].

Lirequinil (Ro 41-3696) is an orally active partial agonist of the benzodiazepine (BDZ) receptor. Lirequinil has the effect of promoting sleep[1].